“Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s141, https://doi.org/10.25251/skin.7.supp.141.